A carregar...
miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A
INTRODUCTION: Triple-negative breast cancer (TNBC) is the most aggressive malignancy of breast cancer, which represents about 20% of all cases. The prognosis of TNBC remains unfavorable due to the lack of targeted therapy and chemoresistance. The aim of this study is to investigate the role of miR-6...
Na minha lista:
| Publicado no: | Cancer Manag Res |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7733386/ https://ncbi.nlm.nih.gov/pubmed/33324107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S276316 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|